| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Pasithea Therapeutics Corp.
13D/A
KTTA · 70261F202
|
3.1% |
3/6/2025
Event 3/1/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.